We are live on ! Find out more
LCM

Laurion Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 75.73%
This Fund
S&P 500
This Quarter Est. Return
+2.87%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$21.4B
AUM Growth
+$4.44B
Cap. Flow
+$3.37B
Cap. Flow %
15.75%
Top 10 Hldgs %
23.93%
Holding
573
New
101
Increased
135
Reduced
75
Closed
168

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$235M
2
AMZN icon
Amazon
AMZN
+$216M
3
ATVI
Activision Blizzard
ATVI
+$191M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$93.2M
5
TSLA icon
Tesla
TSLA
+$76.8M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$114M
2
TGT icon
Target
TGT
+$112M
3
TMUS icon
T-Mobile US
TMUS
+$104M
4
C icon
Citigroup
C
+$99.3M
5
TWTR
Twitter, Inc.
TWTR
+$92.5M

Sector Composition

Rank Sector Weight
1 Technology 3.92%
2 Healthcare 3.45%
3 Consumer Discretionary 3.2%
4 Communication Services 2.88%
5 Utilities 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CORS
351
DELISTED
Corsair Partnering Corporation
CORS
$500K ﹤0.01%
50,000
– –
CTV
352
DELISTED
Innovid Corp.
CTV
$496K ﹤0.01%
290,305
– –
FDMT icon
353
4D Molecular Therapeutics
FDMT
$582M
$475K ﹤0.01%
21,401
-223,722
-91% -$3.46M
PRAX icon
354
Praxis Precision Medicines
PRAX
$10.2B
$468K ﹤0.01%
13,111
-96
-0.7% -$2.99K
IMPL
355
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$468K ﹤0.01%
124,800
– –
RNAM
356
DELISTED
Avidity Biosciences
RNAM
$444K ﹤0.01%
+20,000
New +$298K
BCEL
357
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$394K ﹤0.01%
492,200
– –
XLO icon
358
Xilio Therapeutics
XLO
$60.5M
$384K ﹤0.01%
10,207
– –
NUE icon
359
Nucor
NUE
$62.5B
$382K ﹤0.01%
2,900
+705
+32% +$95.8K
XLY icon
360
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.8B
$349K ﹤0.01%
5,400
+2,000
+59% +$139K
IONQ icon
361
IonQ
IONQ
$15.9B
$345K ﹤0.01%
100,000
– –
MXL icon
362
MaxLinear
MXL
$6.21B
$340K ﹤0.01%
10,000
– –
DAWN
363
DELISTED
Day One Biopharmaceuticals
DAWN
$323K ﹤0.01%
15,000
+763
+5% +$15.7K
VALN
364
Valneva
VALN
$541M
$320K ﹤0.01%
25,000
– –
SQZ
365
DELISTED
SQZ Biotechnologies Company
SQZ
$319K ﹤0.01%
431,400
– –
KRE icon
366
State Street SPDR S&P Regional Banking ETF
KRE
$4.56B
$311K ﹤0.01%
5,300
+900
+20% +$55.4K
TRML
367
DELISTED
Tourmaline Bio
TRML
$304K ﹤0.01%
29,842
– –
NMTR
368
DELISTED
9 Meters Biopharma
NMTR
$287K ﹤0.01%
227,910
– –
HRTX icon
369
Heron Therapeutics
HRTX
$63.4M
$287K ﹤0.01%
114,817
+496
+0.4% +$1.6K
INZY
370
DELISTED
Inozyme Pharma
INZY
$285K ﹤0.01%
271,800
– –
UBER icon
371
Uber
UBER
$159B
$282K ﹤0.01%
+11,405
New +$312K
ACET icon
372
Adicet Bio
ACET
$75.9M
$282K ﹤0.01%
1,970
-3,708
-65% -$925K
APLT
373
DELISTED
Applied Therapeutics
APLT
$263K ﹤0.01%
345,900
– –
HON icon
374
Honeywell
HON
$77B
$257K ﹤0.01%
1,272
+668
+111% +$128K
DNTH icon
375
Dianthus Therapeutics
DNTH
$6.25B
$230K ﹤0.01%
36,394
– –
13 14
15
16 17

Similar funds

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.31B AUM 10.09% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
OCM
Oribel Capital Management New York $2.27B AUM 60.32% 1-Year Est. Return

Laurion Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Laurion Capital Management held 573 positions worth $21.4B, up 26% from $16.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Laurion Capital Management deployed $3.37B of net new capital in Q4 2022, opening 101 new positions and adding to 135 existing holdings. Its largest new stake was Tesla: 405,456 shares worth $49.9M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Target, an estimated $112M trimmed.

  • Laurion Capital Management's largest Q4 2022 buy was Tesla: 405,456 shares worth $49.9M.
  • Laurion Capital Management added most to Apple in Q4 2022, an estimated $235M increase.
  • Laurion Capital Management's biggest Q4 2022 reduction was Target, cutting an estimated $112M.
  • Laurion Capital Management fully exited JPMorgan Chase in Q4 2022, selling an estimated $114M.
  • Laurion Capital Management's ten largest holdings make up 24% of its $21.4B portfolio in Q4 2022.
  • Laurion Capital Management opened 101 new positions and closed 168 in Q4 2022.
  • Laurion Capital Management's portfolio value rose 26% quarter-over-quarter to $21.4B.

Based on Laurion Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.